Literature DB >> 17181739

Osteopontin as biomarker in early invasion by squamous cell carcinoma in tongue.

H Matsuzaki1, K Shima, T Muramatsu, Y Ro, S Hashimoto, T Shibahara, M Shimono.   

Abstract

BACKGROUND: Osteopontin (OPN) expression in squamous cell carcinoma (SCC) of the tongue has not been clearly elucidated.
METHODS: We selected 46 cases of tongue SCC and investigated the expression of OPN by immunohistochemical staining. The immunopositive reaction and score for each case were semiquantitatively evaluated.
RESULTS: Scores were significantly higher in carcinoma nests than in neighboring normal epithelium or epithelial dysplasia. The OPN was expressed clearly in the cytoplasm of carcinoma cells. In cases of early invasive carcinoma, in particular, expression of OPN showed a remarkable increase at the invasion front compared with the non-invaded regions. However, there was no significant correlation between expression of OPN in the primary tumor nest and lymphatic metastasis, recurrence, or survival rate.
CONCLUSION: This suggests that OPN is a useful biomarker of early invasion by SCC in tongue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17181739     DOI: 10.1111/j.1600-0714.2006.00493.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  12 in total

1.  Serum levels of osteopontin as a prognostic factor in patients with oral squamous cell carcinoma.

Authors:  Maryam Mardani; Azadeh Andisheh-Tadbir; Bijan Khademi; Mohammad Javad Fattahi; Shapour Shafiee; Maryam Asad-Zadeh
Journal:  Tumour Biol       Date:  2013-12-14

2.  Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.

Authors:  Wang Likui; Wang Hong; Zhang Shuwen
Journal:  J Gastrointest Surg       Date:  2009-09-18       Impact factor: 3.452

3.  Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.

Authors:  Jung Yeon Kim; Byung-Noe Bae; Kyoung Soo Kim; Eunah Shin; Kyeongmee Park
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679

Review 4.  OPN -Revisited.

Authors:  Vijayanirmala Subraman; Muthukumar Thiyagarajan; N Malathi; Sharada T Rajan
Journal:  J Clin Diagn Res       Date:  2015-06-01

5.  Osteopontin expression in co-cultures of human squamous cell carcinoma-derived cells and osteoblastic cells and its effects on the neoplastic cell phenotype and osteoclastic activation.

Authors:  Lucas Novaes Teixeira; Larissa Moreira Spinola de Castro Raucci; Gabriela Caroline Alonso; Ricardo Della Coletta; Adalberto Luiz Rosa; Paulo Tambasco de Oliveira
Journal:  Tumour Biol       Date:  2016-06-16

6.  Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin.

Authors:  Xiang-Qian Zhao; Jia-Hong Dong; Wen-Zhi Zhang; Zhe Liu
Journal:  Diagn Pathol       Date:  2011-10-13       Impact factor: 2.644

7.  Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.

Authors:  C E Weber; A N Kothari; P Y Wai; N Y Li; J Driver; M A C Zapf; C A Franzen; G N Gupta; C Osipo; A Zlobin; W K Syn; J Zhang; P C Kuo; Z Mi
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

8.  Osteopontin is Critical for Hyperactive mTOR-Induced Tumorigenesis in Oral Squamous Cell Carcinoma.

Authors:  Ning Gan; Sihai Zou; Wenming Hang; Deqin Yang; Xuemei Zhang; Yibing Yin
Journal:  J Cancer       Date:  2017-05-12       Impact factor: 4.207

9.  Biomolecular markers in cancer of the tongue.

Authors:  Daris Ferrari; Carla Codecà; Jessica Fiore; Laura Moneghini; Silvano Bosari; Paolo Foa
Journal:  J Oncol       Date:  2009-08-19       Impact factor: 4.375

10.  Osteopontin and oral carcinogenesis.

Authors:  Shailendra Kapoor
Journal:  J Cell Mol Med       Date:  2008-04-15       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.